DiscoverAWS - Conversations with LeadersHarnessing AI to Revolutionize Drug Discovery
Harnessing AI to Revolutionize Drug Discovery

Harnessing AI to Revolutionize Drug Discovery

Update: 2024-07-02
Share

Description

In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.


Resources:

Amazon Bedrock: https://aws.amazon.com/bedrock/

Amazon Q: https://aws.amazon.com/q/

AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/


Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Harnessing AI to Revolutionize Drug Discovery

Harnessing AI to Revolutionize Drug Discovery